US Food and Drug Administration, PerkinElmer | GenomeWeb

The US Food and Drug Administration has approved as a 510(k) PerkinElmer’s NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit, which will be used to screen newborns for certain metabolic disorders. The test can screen “more than 40” disease markers with one sample, PerkinElmer said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.